The groundbreaking success of the copyright undeniably revolutionized the drug landscape, but betting in companies heavily reliant on unbranded versions presents a challenging picture. While early returns were substantial, the end of patents and the appearance of less expensive alternatives have weakened the customer base. Therefore, a thorough … Read More